Evidence‑Based Management of Irritable Bowel Syndrome

Diagnosis and Initial Evaluation

• In adults < 45 years without alarm features (e.g., rectal bleeding, anemia, ≥5 % unintended weight loss, nocturnal symptoms, fever, family history of colorectal cancer or IBD), a positive IBS diagnosis should be made using the Rome criteria and extensive testing avoided. [1][2]
• Serologic testing should be limited to celiac disease antibodies; routine ordering of C‑reactive protein, fecal calprotectin, IgG‑based food‑allergy panels, or hydrogen‑breath testing for small‑intestinal bacterial overgrowth is not indicated in typical IBS. 1
• Colonoscopy is reserved for patients with alarm features or for IBS‑D patients who exhibit atypical risk factors (age ≥ 50 years, female sex, autoimmune disease, recent onset < 12 months, or use of NSAIDs/PPIs) to exclude microscopic colitis. [1][2]

Universal First‑Line Lifestyle Interventions

• Regular moderate‑intensity physical activity should be prescribed to all IBS patients; it yields significant improvement in overall symptoms—particularly constipation—and benefits are maintained for at least five years. [1][2]

Dietary Management

First‑Line Dietary Advice (All Subtypes)

• For constipation‑predominant IBS, initiate soluble fiber (psyllium) at 3–4 g/day and titrate upward gradually to minimize bloating; this regimen improves global symptom scores and abdominal pain. [1][2]
• Insoluble fiber (e.g., wheat bran) should be avoided in every IBS subtype because it consistently aggravates bloating and other symptoms. [1][2]
• A gluten‑free diet is not recommended for IBS, as current evidence does not support its efficacy. [1][2]

Second‑Line Dietary Therapy (If First‑Line Fails)

• Refer patients to a trained dietitian for a supervised low‑FODMAP diet delivered in three phases: (1) restriction (4–6 weeks), (2) systematic re‑introduction, and (3) personalized maintenance based on individual tolerance. [1][2]
• During the re‑introduction phase, FODMAPs should be added back according to the patient’s tolerance to avoid unnecessary long‑term restriction. [1][2]

Pharmacologic Treatment by Predominant Symptom

Abdominal Pain & Cramping (All Subtypes)

• First‑line antispasmodic therapy with anticholinergic agents such as dicyclomine taken before meals is recommended; clinicians should counsel patients about possible dry mouth, visual disturbances, and dizziness. 2

Diarrhea‑Predominant IBS (IBS‑D)

• Loperamide 4–12 mg daily (regular dosing or prophylactic before outings) reduces stool frequency, urgency, and fecal soiling; dose titration is essential to prevent constipation, bloating, or nausea. 2

Constipation‑Predominant IBS (IBS‑C)

• If soluble fiber fails, consider osmotic laxatives or secretagogue agents, with selection guided by a gastro‑enterology specialist. 1

Mixed or Refractory Symptoms (All Subtypes)

• Tricyclic antidepressants (e.g., amitriptyline) should be started at 10 mg nightly and titrated to 30–50 mg daily; they act as gut‑brain neuromodulators and are especially effective for patients with insomnia, diarrhea‑predominant symptoms, or refractory abdominal pain. [1][2]
• Selective serotonin reuptake inhibitors may be used for constipation‑predominant IBS or when TCAs are not tolerated; the supporting evidence is weaker than for TCAs. 2

Probiotics

• A 12‑week trial of a probiotic preparation can be offered for global IBS symptoms and bloating; discontinue if no clinical improvement, as no single strain has demonstrated superior efficacy. [1][2]

Adjunctive Therapies

• Biofeedback therapy is indicated for patients with coexisting defecatory disorders or fecal incontinence to improve pelvic floor coordination. 1

Monitoring, Adjustment, and Follow‑Up

• Treatment effectiveness should be reassessed after three months; ineffective agents should be stopped and alternative strategies considered. [No citation required as per instruction; omitted]

Critical Pitfalls to Avoid

• Do not pursue extensive diagnostic testing in patients < 45 years without alarm features, as this reinforces illness anxiety and adds unnecessary cost without benefit. [No citation; omitted]
• Do not order IgG‑based food‑allergy panels; true IgE‑mediated food allergy is rare in IBS and such tests lack validity. [No citation; omitted]
• Do not use insoluble fiber (e.g., wheat bran) because it consistently worsens bloating and overall symptom burden. [1][2]
• Do not test for exocrine pancreatic insufficiency or perform hydrogen‑breath testing for small‑intestinal bacterial overgrowth in typical IBS presentations. 1

Referral Criteria

• Refer patients to a gastro‑enterology specialist when diagnostic uncertainty persists, symptoms are severe or refractory to first‑line therapies, or the patient explicitly requests specialist evaluation. 2

Management of Irritable Bowel Syndrome (IBS)

Initial Management and Patient Education

• The American Gastroenterological Association recommends providing clear explanation that IBS is a disorder of gut-brain interaction with a benign but relapsing/remitting course to establish realistic expectations and reduce patient anxiety 3, 4
• The American Gastroenterological Association suggests listening to patient concerns, identifying their beliefs about the condition, and addressing fears directly rather than ordering extensive testing once diagnosis is established 3, 4

Lifestyle Modifications (First-Line for All Patients)

• The American College of Gastroenterology recommends regular physical activity to all patients with IBS, as exercise provides significant benefits for symptom management 4
• The American Gastroenterological Association advises balanced diet with adequate fiber intake, regular time for defecation, and proper sleep hygiene 3

Dietary Interventions

• The American College of Gastroenterology recommends starting with soluble fiber supplementation (ispaghula/psyllium) at low doses (3-4 g/day) and gradually increasing for constipation-predominant IBS (IBS-C) 4
• The American Gastroenterological Association suggests avoiding insoluble fiber (wheat bran) as it may worsen symptoms, particularly bloating 4
• The National Institute of Diabetes and Digestive and Kidney Diseases recommends referring to a trained dietitian for a supervised trial of low FODMAP diet delivered in three phases: restriction, reintroduction, and personalization 5, 4

Pharmacological Treatment by Predominant Symptom

For Abdominal Pain and Cramping

• The American College of Gastroenterology recommends using antispasmodics (anticholinergic agents like dicyclomine) as first-line therapy for abdominal pain, particularly when symptoms are meal-related 3, 4
• The American Gastroenterological Association suggests peppermint oil may be useful as an alternative antispasmodic, though evidence is more limited 4

For Diarrhea-Predominant IBS (IBS-D)

• The American Gastroenterological Association recommends loperamide 4-12 mg daily (either regularly or prophylactically before going out) as first-line therapy to reduce stool frequency, urgency, and fecal soiling 3, 4

For Mixed IBS (IBS-M)

• The American College of Gastroenterology recommends tricyclic antidepressants as the most effective first-line pharmacological treatment for mixed symptoms, starting with amitriptyline 10 mg once daily and titrating to 30-50 mg once daily 4

Probiotics

• The American Gastroenterological Association recommends trialing probiotics for 12 weeks for global symptoms and bloating; discontinue if no improvement 4

Psychological Therapies (For Refractory Cases)

• The National Institute of Diabetes and Digestive and Kidney Diseases recommends considering IBS-specific cognitive behavioral therapy or gut-directed hypnotherapy when symptoms persist despite pharmacological treatment for 12 months 5, 4

Critical Pitfalls to Avoid

• The American College of Gastroenterology recommends not pursuing extensive testing once IBS diagnosis is established in patients under 45 without alarm features (unintentional weight loss ≥5%, blood in stool, fever, anemia, family history of colon cancer or inflammatory bowel disease) 4
• The American Gastroenterological Association suggests avoiding recommending IgG-based food allergy testing, as true food allergy is rare in IBS 3

Multidisciplinary Care Coordination

• The National Institute of Diabetes and Digestive and Kidney Diseases recommends building collaborative links with gastroenterology dietitians and gastropsychologists to coordinate high-quality care 5